Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Bliss GVS Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1985 on BSE, Jul 2010 on NSE
Last close ₹647.50down ₹33.40 (4.91%)BSE ₹648.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹680.90.
30 Oct: open ₹660.00, high ₹670.00, low ₹646.90
52-week range of traded prices to 30 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,885 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.71
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.23%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,45,760
Bliss GVS Pharma shareholder meetings
62 filed, newest first. Page 2 of 2.
Sep 2015
Jul 2015
May 2015
Aug 2014
28 Aug · Meeting
Annual General Meeting of the Company held on August 28, 2014 the following resolutions were passed with absolute majority: 1) Adoption of Financial Statements for the year ended March 31, 2014. 2) Reappointment of Mr. S.R. Vaidya as an Independent Director for 5 consecutive years. 3) Reappointment of M/s B .K Khare & Co. as an Auditor for 3 consecutive years. 4) Declaration of Dividend @50% (i.e. Rs. 0.50/-per share) 5) to approve the remuneration payable to cost auditors, M/s Y.R. Doshi & Associates for the financial Year 2014-15. 6) Renting of Office Premises from Promoters. 7) Loans and Guarantees to Subsidiaries. 8) Power to Borrow Money.
Jul 2014
31 Jul · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from August 18, 2014 to August 22, 2014 (both days inclusive) for the purpose of declaration of Dividend. Further, the Annual General Meeting of the Company is scheduled to be held on August 28, 2014.
Aug 2013
Jul 2013
24 Jul · Meeting
Company has fixed Book Closure from August 5, 2013 to August 9, 2013 (both days inclusive) for the purpose of Declaration of Dividend. Further, the Annual General Meeting of the Company is scheduled to be held on August 14, 2013.
Aug 2012
Jun 2012
25 Jun · Meeting
Annual General Meeting of the Company will be held on August 10, 2012. Further, the Register of Members and the Share Transfer Books of the Company will remain closed from August 06, 2012 to August 10, 2012 (both days inclusive) for the purpose of Declaration of Dividend.
Jul 2011
Aug 2010
3 Aug · Meeting
Meeting of the Shareholders of the Company held on August 03, 2010 : (1) Approved and adopted Profit and Loss Account for the year ended March 31, 2010, Balance Sheet as at that day and the Reports of Directors and Auditors thereon; (2) Appointed Mr. Gautam R Ashra who retires by rotation and eligible offers himself for re-appointment; (3) Reappointed M/s B.K. Khare & Co as auditors of the Company; (4) Declared dividend @ 50% per share; (5) Appointed Dr. Vibha N. Kamath as Whole time Director of the Company; (6) Re-appointed and revised salary of Mr. S. N. Kamath as Managing Director of the Company; and (7) Re-appointed and revised salary of Miss Shruti N. Kamath as Wholetime Director of the Company.